Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 204250, 9 pages
http://dx.doi.org/10.1155/2012/204250
Research Article

Distinct Proteasome Subpopulations in the Alveolar Space of Patients with the Acute Respiratory Distress Syndrome

1Klinik für Anästhesiologie und Intensivmedizin, Universität Duisburg-Essen, Universitätsklinikum Essen, 45122 Essen, Germany
2Institut für Biochemie/CCM, Charité-Universitätsmedizin-Berlin, 13347 Berlin, Germany
3Klinik für Pneumologie und Allergologie, Ruhrlandklinik, Universität Duisburg-Essen, 45239 Essen, Germany
4Max Planck Institute for Infection Biology, Core Facility Protein Analysis, 13125 Berlin, Germany

Received 29 June 2011; Accepted 12 October 2011

Academic Editor: Sascha Flohe

Copyright © 2012 S. U. Sixt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. L. Rock, C. Gramm, L. Rothstein et al., “Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules,” Cell, vol. 78, no. 5, pp. 761–771, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. O. Coux, K. Tanaka, and A. L. Goldberg, “Structure and functions of the 20S and 26S proteasomes,” Annual Review of Biochemistry, vol. 65, pp. 801–847, 1996. View at Google Scholar · View at Scopus
  3. W. Hilt and D. H. Wolf, “Proteasomes: destruction as a programme,” Trends in Biochemical Sciences, vol. 21, no. 3, pp. 96–102, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Voges, P. Zwickl, and W. Baumeister, “The 26S proteasome: a molecular machine designed for controlled proteolysis,” Annual Review of Biochemistry, vol. 68, pp. 1015–1068, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Ciechanover, “The ubiquitin-proteasome pathway: on protein death and cell life,” EMBO Journal, vol. 17, no. 24, pp. 7151–7160, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. M. H. Glickman and A. Ciechanover, “The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction,” Physiological Reviews, vol. 82, no. 2, pp. 373–428, 2002. View at Google Scholar · View at Scopus
  7. F. Kopp, K. B. Hendil, B. Dahlmann, P. Kristensen, A. Sobek, and W. Uerkvitz, “Subunit arrangement in the human 20s proteasome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 7, pp. 2939–2944, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. L. C. Dang, F. D. Melandri, and R. L. Stein, “Kinetic and mechanistic studies on the hydrolysis of ubiquitin C- terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes,” Biochemistry, vol. 37, no. 7, pp. 1868–1879, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. R. L. Goodale, B. Goetzman, and M. B. Visscher, “Hypoxia and iodoacetic acid and alveolocapillary barrier permeability to albumin,” The American Journal of Physiology, vol. 219, no. 5, pp. 1226–1230, 1970. View at Google Scholar · View at Scopus
  10. S. U. Sixt and J. Peters, “Extracellular alveolar proteasome: possible role in lung injury and repair,” Proceedings of the American Thoracic Society, vol. 7, no. 1, pp. 91–96, 2010. View at Google Scholar · View at Scopus
  11. N. Klare, M. Seeger, K. Janek, P. R. Jungblut, and B. Dahlmann, “Intermediate-type 20 S proteasomes in HeLa cells: “asymmetric” subunit composition, diversity and adaptation,” Journal of Molecular Biology, vol. 373, no. 1, pp. 1–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Fruh, M. Gossen, K. Wang, H. Bujard, P. A. Peterson, and Y. Yang, “Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex,” EMBO Journal, vol. 13, no. 14, pp. 3236–3244, 1994. View at Google Scholar · View at Scopus
  13. M. Gaczynska, K. L. Rock, T. Spies, and A. L. Goldberg, “Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 20, pp. 9213–9217, 1994. View at Google Scholar · View at Scopus
  14. M. Gaczynska, A. L. Goldberg, K. Tanaka, K. B. Hendil, and K. L. Rock, “Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-γ-induced subunits LMP2 and LMP7,” Journal of Biological Chemistry, vol. 271, no. 29, pp. 17275–17280, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. H. G. Rammensee, K. Falk, and O. Rötzschke, “Peptides naturally presented by MHC class I molecules,” Annual Review of Immunology, vol. 11, pp. 213–244, 1993. View at Google Scholar · View at Scopus
  16. E. Kruger, U. Kuckelkorn, A. Sijts, and P. M. Kloetzel, “The components of the proteasome system and their role in MHC class I antigen processing,” Reviews of Physiology, Biochemistry and Pharmacology, vol. 148, pp. 81–104, 2003. View at Google Scholar
  17. U. Seifert and E. Kruger, “Remodelling of the ubiquitin-proteasome system in response to interferons,” Biochemical Society Transactions, vol. 36, part 5, pp. 879–884, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. U. Sixt, M. Beiderlinden, H. P. Jennissen, and J. Peters, “Extracellular proteasome in the human alveolar space: a new housekeeping enzyme?” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 292, no. 5, pp. L1280–L1288, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. U. Sixt, M. Adamzik, D. Spyrka et al., “Alveolar extracellular 20S proteasome in patients with acute respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 12, pp. 1098–1106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. G. R. Bernard, A. Artigas, K. L. Brigham et al., “The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 3, part 1, pp. 818–824, 1994. View at Google Scholar · View at Scopus
  21. W. Y. Park, R. B. Goodman, K. P. Steinberg et al., “Cytokine balance in the lungs of patients with acute respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 10, part 1, pp. 1896–1903, 2001. View at Google Scholar · View at Scopus
  22. G. U. Meduri and C. R. Yates, “Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS,” Annals of the New York Academy of Sciences, vol. 1024, pp. 24–53, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. J. F. Murray, M. A. Matthay, J. M. Luce, and M. R. Flick, “An expanded definition of the adult respiratory distress syndrome,” American Review of Respiratory Disease, vol. 138, no. 3, pp. 720–723, 1988. View at Google Scholar · View at Scopus
  24. J. R. le Gall, S. Lemeshow, and F. Saulnier, “A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study,” Journal of the American Medical Association, vol. 270, no. 24, pp. 2957–2963, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. J. L. Vincent, R. Moreno, J. Takala et al., “The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine,” Intensive Care Medicine, vol. 22, no. 7, pp. 707–710, 1996. View at Publisher · View at Google Scholar
  26. Technical recommendations and guidelines for bronchoalveolar lavage (BAL), “Report of the European society of pneumology task group,” European Respiratory Journal, vol. 2, no. 6, pp. 561–585, 1989. View at Google Scholar
  27. R. P. Baughman and P. Haslam, “Report of ERS task force: guidelines for measurement of acellular components and standardization of BAL,” European Respiratory Journal, vol. 14, no. 2, pp. 245–248, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. T. E. King, “The handling and analysis of bronchoalveolar lavage specimens,” in Bronchoalveolar Lavage, R. P. Baughman, Ed., pp. 3–29, Mosby Year Book, St. Louis, Mo, USA, 1992. View at Google Scholar
  29. L. Kuehn and B. Dahlmann, “Proteasome activator PA28 and its interaction with 20S proteasomes,” Archives of Biochemistry and Biophysics, vol. 329, no. 1, pp. 87–96, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Dutaud, L. Aubry, L. Henry et al., “Development and evaluation of a sandwich ELISA for quantification of the 20S proteasome in human plasma,” Journal of Immunological Methods, vol. 260, no. 1-2, pp. 183–193, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Dahlmann, T. Ruppert, L. Kuehn, S. Merforth, and P. M. Kloetzel, “Different proteasome subtypes in a single tissue exhibit different enzymatic properties,” Journal of Molecular Biology, vol. 303, no. 5, pp. 643–653, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Zoeger, M. Blau, K. Egerer, E. Feist, and B. Dahlmann, “Circulating proteasomes are functional and have a subtype pattern distinct from 20S proteasomes in major blood cells,” Clinical Chemistry, vol. 52, no. 11, pp. 2079–2086, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Schmidt, B. Dahlmann, K. Janek et al., “Comprehensive quantitative proteome analysis of 20S proteasome subtypes from rat liver by isotope coded affinity tag and 2-D gel-based approaches,” Proteomics, vol. 6, no. 16, pp. 4622–4632, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Froment, S. Uttenweiler-Joseph, M. P. Bousquet-Dubouch et al., “A quantitative proteomic approach using two-dimensional gel electrophoresis and isotope-coded affinity tag labeling for studying human 20S proteasome heterogeneity,” Proteomics, vol. 5, no. 9, pp. 2351–2363, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. G. A. Roth, B. Moser, C. Krenn et al., “Heightened levels of circulating 20S proteasome in critically ill patients,” European Journal of Clinical Investigation, vol. 35, no. 6, pp. 399–403, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Aki, N. Shimbara, M. Takashina et al., “Interferon-γ induces different subunit organizations and functional diversity of proteasomes,” Journal of Biochemistry, vol. 115, no. 2, pp. 257–269, 1994. View at Google Scholar · View at Scopus
  37. J. Driscoll, M. G. Brown, D. Finley, and J. J. Monaco, “MHC-linked LMP gene products specifically alter peptidase activities of the proteasome,” Nature, vol. 365, no. 6443, pp. 262–264, 1993. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Groll, M. Bochtler, H. Brandstetter, T. Clausen, and R. Huber, “Molecular machines for protein degradation,” ChemBioChem, vol. 6, no. 2, pp. 222–256, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Lehmann, K. Janek, B. Braun, P. M. Kloetzel, and C. Enenkel, “20 S proteasomes are imported as precursor complexes into the nucleus of yeast,” Journal of Molecular Biology, vol. 317, no. 3, pp. 401–413, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Chen and M. Hochstrasser, “Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly,” Cell, vol. 86, no. 6, pp. 961–972, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Schmidtke, R. Kraft, S. Kostka et al., “Analysis of mammalian 20S proteasome biogenesis: the maturation of β-subunits is an ordered two-step mechanism involving autocatalysis,” EMBO Journal, vol. 15, no. 24, pp. 6887–6898, 1996. View at Google Scholar · View at Scopus
  42. P. M. Suter, “Lung inflammation in ARDS—friend or foe?” New England Journal of Medicine, vol. 354, no. 16, pp. 1739–1742, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. P. M. Suter, S. Suter, E. Girardin, P. Roux-Lombard, G. E. Grau, and J. M. Dayer, “High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis,” American Review of Respiratory Disease, vol. 145, no. 5, pp. 1016–1022, 1992. View at Google Scholar · View at Scopus
  44. C. Y. Castro, “ARDS and diffuse alveolar damage: a pathologist's perspective,” Seminars in Thoracic and Cardiovascular Surgery, vol. 18, no. 1, pp. 13–19, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Beninga, K. L. Rock, and A. L. Goldberg, “Interferon-γ can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase,” Journal of Biological Chemistry, vol. 273, no. 30, pp. 18734–18742, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Meng, R. Mohan, B. H. B. Kwok, M. Elofsson, N. Sin, and C. M. Crews, “Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 18, pp. 10403–10408, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Niedermann, G. King, S. Butz et al., “The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 16, pp. 8572–8577, 1996. View at Publisher · View at Google Scholar · View at Scopus